News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSpecifics Technologies Corporation (BSTC) Reports Third Quarter 2013 Financial Results



11/12/2013 9:49:11 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

LYNBROOK, N.Y., Nov. 12, 2013 -- /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® (the EU tradename for CCH) in the EU, today reported its financial results for the third quarter ended September 30, 2013 and provided a corporate update.

Help employers find you! Check out all the jobs and post your resume.

Read at Sacramento Bee


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES